Anterios Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $478M

Anterios General Information

Description

Developer of botulinum products for therapeutic and aesthetic applications. The company is a privately held, clinical-stage bio-pharmaceutical company that is developing next-generation botulinum-based prescription products for medical dermatology and aesthetic medicine.

Contact Information

Website
www.anteriosinc.com
Formerly Known As
Encapsion, Encapsion Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 60 East 42nd Street
  • Suite 1160
  • New York, NY 10165
  • United States
+1 (212)
Primary Industry
Drug Discovery
Acquirer
Allergan
Vertical(s)
Life Sciences
Corporate Office
  • 60 East 42nd Street
  • Suite 1160
  • New York, NY 10165
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anterios Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 06-Jan-2016 $478M Completed Product Development
6. IPO 30-Apr-2015 Cancelled Product Development
5. Later Stage VC (Series B3) 24-Apr-2013 Completed Startup
4. Early Stage VC (Series B3) 25-Jul-2011 Completed Startup
3. Early Stage VC (Series B2) 29-Dec-2010 Completed Startup
2. Early Stage VC (Series B) 30-Nov-2009 $7.78M $15.3M Completed Startup
1. Early Stage VC (Series A) 26-Jan-2007 $7.5M $7.5M Completed Startup
To view Anterios’s complete valuation and funding history, request access »

Anterios Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B3
Series B2
Series B 1,136,466 $0.000100 8% $8.8 $8.8 1x $8.8 8.27%
Series A 2,529,425 $0.000100 8% $2.97 $2.97 1x $2.97 23.67%
To view Anterios’s complete cap table history, request access »

Anterios Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of botulinum products for therapeutic and aesthetic applications. The company is a privately held, clinical-st
Drug Discovery
New York, NY
11 As of 2016

Hampton, NJ
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anterios Competitors (40)

One of Anterios’s 40 competitors is Celldex, a Formerly VC-backed company based in Hampton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celldex Formerly VC-backed Hampton, NJ
Novartis Corporation Basel, Switzerland
Ipsen Formerly PE-Backed Paris, France
Alkermes Formerly VC-backed Dublin, Ireland
Hoechst Pakistan Corporate Backed or Acquired Karachi, Pakistan
You’re viewing 5 of 40 competitors. Get the full list »

Anterios Patents

  • 128

    Total Documents Applications and Grants

  • Total Patents Families

  • 44

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

Anterios Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015252947-A1 Demonstrable efficacy across or within patient populations Active 01-May-2014
AU-2015252947-B2 Demonstrable efficacy across or within patient populations Active 01-May-2014
AU-2020250248-A1 Demonstrable efficacy across or within patient populations Inactive 01-May-2014
CA-2947603-A1 Demonstrable efficacy across or within patient populations Inactive 01-May-2014
EP-3137055-A1 Demonstrable efficacy across or within patient populations Inactive 01-May-2014 A61K38/4893
To view Anterios’s complete patent history, request access »

Anterios Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anterios Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Colt Ventures Family Office Minority
DRW Venture Partners Corporate Venture Capital Minority
Praesideo Management Hedge Fund Minority
Quantum Technology Partners Venture Capital Minority
Scientific Health Development Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Anterios Investments (1)

Anterios’s most recent deal was a Later Stage VC with Specialist Doctors for . The deal was made on 20-Apr-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Specialist Doctors 20-Apr-2017 Later Stage VC Clinics/Outpatient Services
To view Anterios’s complete investments history, request access »

Ready to get started?

Request a free trial

Anterios FAQs

  • When was Anterios founded?

    Anterios was founded in 2006.

  • Where is Anterios headquartered?

    Anterios is headquartered in New York, NY.

  • What is the size of Anterios?

    Anterios has 11 total employees.

  • What industry is Anterios in?

    Anterios’s primary industry is Drug Discovery.

  • Is Anterios a private or public company?

    Anterios is a Private company.

  • What is the current valuation of Anterios?

    The current valuation of Anterios is .

  • What is Anterios’s current revenue?

    The current revenue for Anterios is .

  • How much funding has Anterios raised over time?

    Anterios has raised $27.7M.

  • Who are Anterios’s investors?

    Colt Ventures, DRW Venture Partners, Praesideo Management, Quantum Technology Partners, and Scientific Health Development are 5 of 7 investors who have invested in Anterios.

  • Who are Anterios’s competitors?

    Celldex, Novartis, Ipsen, Alkermes, and Hoechst Pakistan are some of the 40 competitors of Anterios.

  • When was Anterios acquired?

    Anterios was acquired on 06-Jan-2016.

  • Who acquired Anterios?

    Anterios was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process